Which birth control dose works best for PCOS? new study compares 20µg vs 30µg
NCT ID NCT07318337
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at two different doses of a birth control pill (drospirenone-ethinyl estradiol) in 60 women with PCOS. The goal was to see which dose better lowers a hormone marker called free androgen index. Participants took either a 20µg or 30µg dose daily for 3 months, and their hormone levels were measured before and after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Drospirenone-ethinyl estradiol (birth control pill)
What this could lead to
If successful, this could help doctors choose the best dose of birth control to manage hormone levels in women with PCOS, potentially reducing side effects.
What could go wrong
This is a small, completed study with only 60 participants, so results may not apply to everyone. The treatment only lasts 3 months, so long-term effects are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PCOS (POLYCYSTIC OVARY SYNDROME) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bangladesh Medical University
Dhaka, 1000, Bangladesh